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Abstract
Background: Extrapontine myelinolysis presenting with extra pyramidal features suggestive of
parkinsonism may be a challenging clinical syndrome. Clinicians should maintain their vigilance while
correcting electrolyte imbalances, especially with associated co-morbidity.
Case presentation: A 41-year-old woman presented with acute parkinsonism like features while
on a holiday. This followed slow correction of hyponatraemia after repeated vomiting. MRI changes
were suggestive of Extrapontine myelinolysis(EPM). This case is at variance with four previous cases
reported in the medical literature in that the patient made a full clinical recovery and the MR
changes resolved with symptomatic support alone.
Conclusion:  Extrapontine myelinolysis could make a complete recovery with symptomatic
support alone. During hyponatraemia correction, rapid osmotic shifts of fluid that cause
hypernatremia, causes myelinolysis rather than absolute serum sodium level.
Even gradual correction of hyponatraemia can produce myelinolysis, especially with pre-existing 
malnourishment, alcoholism, drug misuse, Addison's disease and immuno-suppression. Pallidial 
sparing is typical of EPM in MRI scans.
Background
Extrapontine myelinolysis presenting with parkinsonism
like features may be a challenging clinical syndrome with
wide differential including neurodegenerative disease,
vascular and metabolic conditions and exposure to toxin
(see table 1). We report a case of EPM presenting with
extra pyramidal features and florid disability following
correction of hyponatraemia and where the patient made
a rapid and complete recovery.
Case presentation
A 41-year-old caucasian woman presented with ataxia,
tremor, dysarthria, and cogwheel rigidity. Two weeks prior
to admission she had been on a holiday in southwest
Africa. After three days in the hot climate there, she devel-
oped tiredness and fatigue with profuse vomiting. In hos-
pital, routine bloods showed low sodium less than 100
mmol/l and raised potassium at 5.9 mmol/l. Other rou-
tine blood parameters were normal and random cortisol
was low at 136 nmol/l.
Using intravenous normal saline, she was started on grad-
ual sodium replacement aiming at 8 mmol/l correction
per day with daily electrolyte monitoring. The sodium
improved to 130 mmol/l over 5 days. Over the next week
she developed dysarthria and ataxia with rigidity and
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tremor. MRI showed faint symmetrical change laterally in
the basal ganglia that were not felt to be significant.
With a deteriorating condition and no clear diagnosis, she
was flown back to the UK as an emergency for assessment
at our tertiary neurological centre.
She had been diagnosed with coeliac disease at the age of
14 and maintained close dietary control. Two months
prior to her holiday, she was found to have hypothy-
roidism and had been started on thyroxine 25 mcg once a
day. There was no other past medical or surgical history.
On examination she was slim and under-nourished with
a noticeable tan. She was afebrile and pulse and blood
pressure were normal. Cardiovascular, respiratory and
abdominal examinations were normal. Glasgow coma
scale was 14/15. She was unable to speak, but was
responding to questions with grunting and communicat-
ing with great difficulty using a finger-board.
The cranial nerves and fundus were normal. Tone was uni-
formly increased with cogwheel rigidity and tremor.
Remaining neurological examination was normal.
The blood tests were normal on admission including the
hepatic and renal functions. Sodium was 135 and potas-
sium 3.9.
Thyroid functions were normal and thyroid peroxidase
antibody was negative. The serum cortisol was low at 83
nmol/l and glucose was normal. A synacthen test was
diagnostic of Addison's disease and her adrenal antibod-
ies were positive. So, Addison's disease, exacerbated by
dehydration and vomiting, had been the cause for her
hyponatraemia.
Chest Xray, ECG and CT Scan of brain were normal.
At this stage, a metabolic insult to the brain due to
osmotic shift during correction of hyponatraemia was
thought of clinically and an MRI scan was requested.
MRI following transfer showed symmetrical hyperinten-
sity on the T2-weighted images within the caudate and
putamen (Fig 1) and in FLAIR T2 images (Fig 3). There
were absolutely no changes within the pons in T2-
weighted images (Fig 4). These changes did not show
marked progression in comparison with the MR done
soon after the metabolic insult. There were no changes
within the globus pallidus, cerebellum or within cerebral
white matter.
She was treated with hydrocortisone 200 mg tds intrave-
nously and thyroxine 100 mcg daily. Fludrocortisone was
subsequently added. Her neurological symptoms were
controlled with Baclofen 20 mg bd and LevoDopa/carbi-
dopa 100/25 mg tds. She improved markedly and levo-
dopa therapy was no longer required after day 10.
Baclofen was also withdrawn and she returned to work
within 2 months.
Follow-up MRI 2 months later showed significant resolu-
tion of the basal ganglia changes (Fig 2).
Conclusion
The patient presented with features suggestive of parkin-
sonism, which had developed acutely following correc-
Table 1: Differential Diagnosis of Extrapyramidal syndrome.
Hereditary disorders
• Wilson's disease
• Huntington's disease
Vascular parkinsonism
• Infarcts
• Vasculitis
Structural lesions
• Gliomas
• Meningioma
Hypoxic injury Infections
• ADEM(acute demyelinating encephalomyelitis)
• Postencephalitic
• Creutzfeldt-jakob disease
Metabolic
• Central and Extrapontine myelinolysis
• Hypoparathyroidism
Mitochondrial cytopathies Posttraumatic Drugs
phenothiazines, butyrophenones, thioxanthenes Metoclopramide, methyldopa, reserpine, verapamil, flunarizine, amiodarone.
Toxins
carbon monoxide, cyanide, mptp, manganese.BMC Neurology 2006, 6:33 http://www.biomedcentral.com/1471-2377/6/33
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tion of severe hyponatraemia. The history and
examination excluded the majority of conditions in Table
1.
Central pontine myelinolysis (CPM) may follow correc-
tion of hyponatraemia and generally presents with tetra-
paresis and brain stem dysfunction that may include
pontine dysfunction, pseudobulbar palsy and a 'locked-
in' syndrome. EPM has been described in 10% of patients
with CPM [1], however extra-pyramidal symptoms are a
rarity because these are masked by pyramidal tract and
brain stem dysfunction.
In our patient, features of CPM were absent. There was no
depression in conscious level, 'locked-in' syndrome, tetra-
plegia, pseudobulbar palsy, nystagmus or cranial nerve
palsy. Positive findings included tremor, decreased speech
and oro-bucco-lingual movements. This constellation of
findings, which may be attributed to striatal dysfunction,
has been described in isolated cases of EPM [2]. EPM may
involve the basal ganglia, thalamus, cerebellum and sub-
cortical white matter. Within the zone of demyelination,
blood vessels, neurons and axis cylinders are largely
spared and inflammation is absent [3].
In previous reports, the rapid correction of serum sodium
to normal, or change in serum sodium greater than 25
mmol/l within 48 hours, particularly when associated
with hypoxia, were linked to myelinolysis [4]. Recent
reports suggests hyperosmolality and rapid osmotic shifts
of fluid that cause hypernatremia [5], in addition to
hypoglycemia, hypokalemia and azotemia, causes mye-
linolysis rather than absolute serum sodium level.[3] Pre-
existing malnourishment, alcoholism, drug misuse, Addi-
son's disease and immuno-suppression all increase the
risk of myelin damage[2].
Symptoms and radiographic changes typically occur
between 7 and 14 days after acute osmotic shift[3].
Osmotic myelinolysis typically cause trident-shaped sig-
nal change within the pons on T2-weighted images[8].
T2 weighted magnetic resonance scan image after two  months showing marked improvement, mainly in putamen  (long arrow) Figure 2
T2 weighted magnetic resonance scan image after two 
months showing marked improvement, mainly in putamen 
(long arrow).
T2 weighted magnetic resonance scan image showing bilater- ally symmetrical hyperintensities in Caudate nucleus (small,  thin arrow), Putamen (long arrow), with sparing of Globus  Pallidus (broad arrow), suggestive of Extrapontine myelinoly- sis Figure 1
T2 weighted magnetic resonance scan image showing bilater-
ally symmetrical hyperintensities in Caudate nucleus (small, 
thin arrow), Putamen (long arrow), with sparing of Globus 
Pallidus (broad arrow), suggestive of Extrapontine myelinoly-
sis.BMC Neurology 2006, 6:33 http://www.biomedcentral.com/1471-2377/6/33
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There is sparing of the cortico-spinal tracts and the teg-
mentum. This radiological appearance may persist despite
clinical improvement[7]. Extrapontine changes have been
described in the basal ganglia, white matter and cerebel-
lum. Typically there is pallidal sparing[8]. In this case, the
history of low sodum with subsequent correction, the
clinical syndrome and the basal ganglia changes with
sparing of the globus pallidus were strong pointers to the
diagnosis of EPM, despite the absence of pontine changes.
Bilateral signal change confined to the putamen, globus
pallidus or thalamus may be seen in perinatal hypoxic-
ischaemic injury and in Wilson's disease. There is pre-
dominant pallidal involvement in carbon monoxide poi-
soning and metabolic disorders such as Leigh disease.
Patchy multifocal signal change may be seen in the basal
ganglia in ADEM, encephalitis including Creutzfeldt-
Jakob, lupus vasculitis or indeed any vascular disease
involving perforators, deep venous occlusion (typically
thalamic) and the mitochondrial cytopathies [6]. In
recent writings on this subject, favourable outcome was
observed for myelinolysis in patients with adrenal failure
in the background of Polyglandular autoimmune syn-
drome and prolactinoma [9,10]. The destruction of the
myelin alone without involvement of the axis cylinders or
blood vessels because of rapid osmotic shift might explain
our patients prompt clinical and radiological improve-
ment.
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T2 weighted magnetic resonance scan image of pons showing  absolutely no changes Figure 4
T2 weighted magnetic resonance scan image of pons showing 
absolutely no changes.
T2 weighted FLAIR images of magnetic resonance scan show- ing bilaterally symmetrical hyperintensities in Caudate  nucleus (small, thin arrow), Putamen (long arrow), with spar- ing of Globus Pallidus (broad arrow), suggestive of Extrapon- tine myelinolysis Figure 3
T2 weighted FLAIR images of magnetic resonance scan show-
ing bilaterally symmetrical hyperintensities in Caudate 
nucleus (small, thin arrow), Putamen (long arrow), with spar-
ing of Globus Pallidus (broad arrow), suggestive of Extrapon-
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